Earth Science Tech Inc. (OTCQB: ETST), a diversified holding company operating across healthcare, pharmacy, technology, telemedicine, real estate, and consumer products, is leveraging synergies among its subsidiaries to support long-term growth and generate dependable revenue. At the center of this strategy is Avenvi LLC, its real estate and asset management subsidiary, which contributes through a diversified real estate portfolio, property development expertise, and financing solutions for property purchasers. The integration matters because it demonstrates how ETST is building a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment.
Avenvi not only manages investments and oversees ETST’s share repurchase program but also provides essential physical infrastructure for the company’s expanding pharmacy operations. This includes housing the standalone Mister Meds compounding pharmacy in Texas. By aligning real estate capabilities with healthcare operations, Avenvi plays a critical role in strengthening ETST’s diversified business model and creating opportunities for sustainable growth. The company’s principal operating strategy is to build a vertically integrated healthcare platform, and the seamless integration of patient care—from consultation to fulfillment—is achieved through the synergy of specialized subsidiaries.
For investors, the announcement signals a disciplined approach to capital allocation and operational integration that could enhance long-term value. The real estate subsidiary’s support of the pharmacy business reduces reliance on external facilities and may improve cost efficiency, while the share repurchase program underscores a commitment to shareholder returns. As ETST continues to expand its healthcare footprint, the role of Avenvi in providing physical infrastructure and financing solutions becomes increasingly important. The full article is available at https://ibn.fm/AlJDF, and more information about the company can be found at www.EarthScienceTech.com.
The news is being distributed through BioMedWire, a specialized communications platform focused on biotechnology, biomedical sciences, and life sciences. BioMedWire is part of the Dynamic Brand Portfolio at IBN, which provides wire solutions via InvestorWire, editorial syndication to over 5,000 outlets, press release enhancement, social media distribution, and tailored corporate communications solutions. This broad reach ensures that developments like ETST’s strategic integration reach a wide audience of investors and industry observers. For ongoing updates on ETST, the company’s newsroom is available at https://ibn.fm/ETST. BioMedWire’s full terms of use and disclaimers are available at https://www.BioMedWire.com/Disclaimer.
